SYNDAX PHARMACEUTICALS INC (SNDX) Stock Institutional Owners
SYNDAX PHARMACEUTICALS INC (SNDX) is held by 1 institutional investors with a total value of $11.45M. This comprehensive analysis highlights the top institutional holders led by Renaissance Technologies LLC, and others, who collectively account for nearly 100% of the total institutional ownership.Renaissance Technologies LLC remains the largest institutional holder with a position worth $11.45M. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- SYNDAX PHARMACEUTICALS INC (SNDX) stock institutional trading activity
- SYNDAX PHARMACEUTICALS INC (SNDX) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Renaissance Technologies LLC | Jim Simons | 0.02% | 544,800 | $11,446,248 |
Frequently asked questions about SNDX
Who owns the most SNDX stock?
The largest holders of SNDX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for SYNDAX PHARMACEUTICALS INC (SNDX).
Is SNDX widely held by superinvestors?
Many widely followed stocks like SNDX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly SNDX is represented among the institutional managers we track.